>>> US After Hours Summary: CURI +22.1%, OMER +20.8%, HLIT +18.8%, TBBB +13.8% s

After Hours Summary: CURI +22.1%, OMER +20.8%, HLIT +18.8%, TBBB +13.8% sharply higher on earnings; STUB -14.8%, CBRS -14.7%, CSCO -3.9%, COHR -3% lower on earnings

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: CURI +22.1%, OMER +20.8%, HLIT +18.8%, TBBB +13.8%, NOA +11.8%, ENS +11.7% (also increases dividend), FOSL +10.1%, GO +9.1%, PESI +7%, EQPT +5.5%, JACK +3.8%, ALLO +3.4% (also files for $500 mln mixed shelf offering), AZ +2%

Companies trading higher in after hours in reaction to news: AVB +6.7% (co and EQR win shareholder approval for merger), ISSC +4.3% (to supply avionics and main display system for eVTOL program), PTCT +2.1% (to acquire Sangamo's BLA-stage ST-920 Fabry gene therapy for $111 mln), FUL +1.1% (confirms receipt of cash proposal for Building Adhesive Solutions unit), HOOD +0.4% (July operating data), AB +0.3% (reports July AUM), PHM +0.3% (master repurchase agreement with TFC), FRMI +0.3% (names new CEO), NEE +0.2% (reaches funding milestone for up to 10 GW of gas generation in Texas and Pennsylvania), PFE +0.2% (CEO insider purchase), LMT +0.1% (awarded a $211.4 mln modification to Missile Defense Agency contract)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: STUB -14.8%, CBRS -14.7%, AOSL -13%, SPCE -9.4%, KE -8.6%, REZI -6.8% (also names new CFO), PAAS -6%, LFTO -5.4%, SPIR -5%, AVEX -4.2% (also to acquire BlackSea Technologies), ANDG -4%, CSCO -3.9%, ENVX -3.2%, COHR -3%, INFQ -2.7%, CEPL -2.1%, BTGO -1% (also CFO to retire; authorizes $50 mln buyback), STAA -0.7%

Companies trading lower in after hours in reaction to news: OTLK -14.4% (stock offering), DKL -12.5% (common unit offering), DOV -5.6% (completes acquisition of Cloeren), WYFI -3.8% (partners with Krambu for 100MW of GPU data center capacity starting in 2027), OPRX -2.4% (names new CFO), SHAZ -1.9% (stock offering by selling stockholders), LCID -1.1% (files resale prospectus supplement), RPRX -0.1% (to fund Zealand Pharma with $100 mln for rusfertide economics)